University Hospitals Birmingham NHS Foundation Trust

Reports

Status Drug name NICE TAs Comments
Status: Red Picolax

Bowel cancer screening

Status: Amber Pilocarpine eye drops

Specialist ophthalmologist recommendation - 1%, 2% and 4% eye drops

Status: Green Pilocarpine hydrochloride tablets (Salagen)

Licensed for treatment of xerostomia following irradiation for head and neck cancer; dry mouth and dry eyes in Sjögren's syndrome. Effective only in patients who have residual salivary gland function. 

Status: Red Pilocarpine SDU

Specialist ophthalmologist recommendation

Status: Red Pirenzipine

Unlicensed

Status: Red Pirfenidone

Hospital only

Status: Red Pixantrone

For hospital use only

Status: Green Pneumococcal polysaccharide vaccine (Pneumovax®II)

Protects from each of 23 types of pneumococcus

Status: Green Pneumococcal polysaccharude conjugate vaccine (adsorbed) (Prevenar 13®, Synflorix®)

For use in childhood immunisation programme. Protects against 13 strands of pneumococcus. Supported with PGD.

Status: Red Pomalidomide

Hospital use only

Drug status key

Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.

Grey

Grey

Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.

Red

Red

Initiation and maintenance of prescribing by specialists only.

Amber

Amber

Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.

Green

Green

Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.

Blue

Blue

Under review at University Hospitals Birmingham NHS Foundation Trust.

Building healthier lives
Back to top